Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

EMail:

Free daily newsletter every morning

Content
Signals
All indicators - Medium term
Coloplast BDec 16, 2025
Rockwool AS, ser ADec 16, 2025
Embla Medical hf.Dec 16, 2025
EgnsINVEST Ejendomme TDec 16, 2025
Scandinavian Medical SDec 16, 2025

The market showed a small loss Tuesday, and OMX Copenhagen 25 GI ended the day at 2132 points, which is a decline of 0.3 percent.

58 shares showed a gain and 69 showed a loss. 22 shares were unchanged and closed at the same price as the previous day. There was no trading in 3 shares.

Total value of the trading volume for shares and primary capital certificates Tuesday was approximately 6.1 billion.

Per Aarsleff Holding B rose sharply to close at 798 kroner, up 6.1 percent. The previous time the stock gained this much was Nov 22. 2024, when it closed up 7.9 percent. It also looks good technically. The stock is trend wise positive in the medium term, has support at 710 kroner and a further increase is indicated.
Shape Robotics ended with a steep loss of 31.3 percent and closed at 2.70 kroner. We must go back to Nov 28 to find an equally steep drop. That time the stock lost 53.0 percent. The stock has now fallen for the seventh day in a row. It does not look good technically either. The stock is trend wise negative in the medium term, has resistance at 9.00 kroner and a further decline is indicated.
ALK-Abelló B ended with a steep loss of 2.8 percent and closed at 218 kroner. We must go back to Aug 8 to find an equally steep drop. That time the stock lost 3.7 percent. The stock is trend wise positive in the medium term.
A.P. Møller - Mærsk A moved horizontally and closed at 14620 kroner (+0.2 percent). The stock has thereby closed up 12 out of the past 15 days and this past month the stock has gained as much as 15.1 percent. The stock is trend wise positive in the medium term, has marginally broken up through resistance at 14500 kroner and a further increase is indicated.
Danske Bank showed a small gain and ended the day at 308 kroner, which is an increase of 0.5 percent. The stock has thereby closed up 15 out of the past 20 days. Technically it also looks good. The stock is trend wise positive in the medium term, has support at 260 kroner and a further increase is indicated.

US 500 weakly lower Tuesday
The market showed a small loss Tuesday, and S&P 500 ended the day at 6800 points, which is a decline of 0.2 percent.

Stockholmsbörsen weakly lower Tuesday
The market showed a small loss Tuesday, and OMX Stockholm PI ended the day at 1021 points, which is a decline of 0.6 percent.

Indices
OMX Copenhagen 25 GI
arrow green   Positive Candidate
OMX Copenhagen 25 GI shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index has met the objective at 2162 after a break of the rectangle formation. The price has now fallen, but the formation indicates further rise. The index is approacing resistance at 2180 points, which may give a negative reaction. However, a break upwards through 2180 points will be a positive signal. The index is overall assessed as technically positive for the medium long term.
S&P 500
arrow yellow   Neutral
S&P 500 has broken through the floor of a rising trend channel in the medium long term. This indicates a slower rising rate at first, or the start of a more horizontal development. The index is moving within a rectangle formation between support at 6531 and resistance at 6902. A decisive break through one of these levels indicates the new direction for the index. The index is approacing resistance at 6900 points, which may give a negative reaction. However, a break upwards through 6900 points will be a positive signal. The index is overall assessed as technically neutral for the medium long term.
OMX Stockholm PI
arrow green   Positive Candidate
OMX Stockholm PI shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. The index is testing support at points 1017. This could give a positive reaction, but a downward breakthrough of points 1017 means a negative signal. The index is assessed as technically positive for the medium long term.
Today´s Case
ISS (ISS) Price 213.60, Dec 16, 2025
chart
ISS is in a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the stock has support at approximately 167 kroner. The volume balance is negative and weakens the stock in the short term. The stock is overall assessed as technically positive for the medium long term.
Recommendation: Positive
Latest days indices
AEX-1.12%935.14
CAC40-0.23%8106.16
COMPX0.23%23111.46
DAX-0.63%24077
HEX-0.09%11925.56
N100-0.52%1697.40
OMXC25GI-0.34%2132.35
OMXSPI-0.62%1021.26
OSEBX-0.67%1635.99
PSI20-0.16%8062.05
TECDAX-0.45%3534.52
BUK100P-0.90%971.08
EURUSD0.21%1.1774
CL (OIL)-2.73%55.27
Indices Evaluations
 SML
AEXposposneutral
CAC40neutralposneutral
COMPXpospospos
DAXposnegpos
HEXneutralneutralpos
N100pospospos
OMXC25GIposposneg
OMXSPIpospospos
OSEBXpospospos
PSI20pospospos
TECDAXnegnegpos
BUK100Ppospospos
EURUSDpospospos
CL (OIL)negnegneg

S: Short term.    M: Medium term.    L: Long term.
Stock Exchange barometer
Københavns Fondsbørs - Medium term
 
      
39% 35% 26%
 71 Buy Candidates
 64 Neutral
 46 Sell Candidates
Track what the insiders are doing! Insider buys in green, insider sales in red.
 
   Last month:
   75% Positive
   33 Positive
   11 Negative
Disclaimer Copyright © 2025 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Cancel Analysis News
[ Back to default newsletter setup ]

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.